Application of n.c.a. 4-[18F]fluorophenol in diaryl ether syntheses of 2-(4-[18F]fluorophenoxy)-benzylamines

Journal of Labelled Compounds and Radiopharmaceuticals

Volumn 47, Issue 7, 2004, Pages 443-455

  Stoll, Timo ^a   Ermert, Johannes ^a   Oya, Shunichi ^b   Kung, Hank F ^b   Coenen, Heinz H ^a  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

2 (4 18F fluorophenoxy) N,N dimethylbenzylamine; Diaryl ether synthesis; n.c.a. 4 18F fluorophenol; Radiofluorination; SERT

Indexed keywords

COPPER COMPOUNDS; ETHERS;

2-(4-[18F]FLUOROPHENOXY)-N,N-DIMETHYLBENZYLAMINE; ALKYL ARYL ETHERS; BENZYLAMINES; DIARYL ETHER SYNTHESIS; DIARYL ETHERS; NO-CARRIER-ADDED 4-[18F] FLUOROPHENOL; RADIOFLUORINATION; SEROTONIN REUPTAKE TRANSPORTER SITE; SPECTRA'S; SYNTHETIC METHODS;

AMIDES;

2 (4 FLUOROPHENOXY) N METHYLBENZYLAMINE F 18; 2 (4 FLUOROPHENOXY) N,N DIMETHYLBENZYLAMINE F 18; 2 (4 FLUOROPHENOXY)BENZYLAMINE F 18; 2 BROMOBENZOIC ACID AMIDE; 4 FLUOROPHENOL F 18; 5 IODO 2 [2 (DIMETHYLAMINO)METHYL]PHENOXYBENZYL ALCOHOL I 123; ACETONITRILE DERIVATIVE; BENZAMIDE DERIVATIVE; BENZYL ALCOHOL DERIVATIVE; BENZYLAMINE DERIVATIVE; CARRIER PROTEIN; COPPER DERIVATIVE; ETHER DERIVATIVE; FLUORINE 18; IODINE 123; PHENOL DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SEROTONIN REUPTAKE TRANSPORTER; SEROTONIN TRANSPORTER; TETRAKIS(ACETONITRILE)COPPER HEXAFLUOROPHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG SYNTHESIS; FLUORINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; ISOTOPE LABELING; MELTING POINT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; SWINE;

EID: 3142770481     PISSN: 03624803     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlcr.828     Document Type: Article

References (32)

1. Lemaire C. PET studies on amino acid metabolism and protein synthesis. In Developments in Nuclear Medicine, Mazoyer B, Weiss WD, Comar D (eds). Kluwer Academic Publishers: Dordrecht, 1993; 89-108.
2. Ding YS, Fowler JS, Gatley SJ, Dewey SL, Wolf AP. J Med Chem 1991; 34: 767-771.
3. Langer O, Dollé F, Valette H, Halldin C, Vaufrey F, Fuseau C, Coulon C, Ottaviani M, Nagren K, Bottlaender M, Maziere B, Crouzel C. Bioorg Med Chem 2001; 9: 677-694.
4. Ludwig T, Gail R, Coenen HH. J Nucl Med 1998; 39: P72.
5. Forngren T, Andersson Y, Lamm B, Långström B. Acta Chem Scand 1998; 52: 475-479.
6. Allain-Barbier L, Lasne MC, Perrio-Huard C, Moreau B, Barré L. Acta Chem Scand 1998; 52: 480-489.
7. Wüst FR, Kniess T. J Label Compd Radiopharm 2003; 46: 699-713.
8. Ludwig T, Ermert J, Coenen HH. Nucl Med Biol 2002; 29: 255-262.
9. Zhuang ZP, Choi SR, Hou C, Mu M, Kung MP, Acton PD, Kung HF. Nucl Med Biol 2000; 27: 169-175.
10. Acton PD, Mu M, Plossl K, Hou C, Siciliano M, Zhuang ZP, Oya S, Choi SR, Kung HF. Eur J Nucl Med 1999; 26: 1359-1362.
11. Suehiro M, Scheffel U, Dannals RF, Ravert HT, Ricaurte GA, Wagner Jr HN. J Nucl Med 1993; 34: 120-127.
12. Szabo Z, McCann DU, Wilson AA, Scheffel U et al. J Nucl Med 2002; 43: 678-692.
13. Parsey RV, Kegeles LS, Hwang DR, Simpson N, Abi-Dargham A, Mawlawi O, Silfstein M, Van Heertum RL, Mann JJ, Laruelle M. J Nucl Med 2000; 41: 1465-1477.
14. Oya S, Kung M-P, Acton PD, Mu M, Hou C, Kung HF. J Med Chem 1999; 42: 333-335.
15. Kung M-P, Hou C, Oya S, Mu M, Acton PD, Kung HF. Eur J Nucl Med 1999; 26: 844-853.
16. Oya S, Choi S-R, Hou C, Mu M, Kung M-P, Acton PD, Siciliano M, Kung HF. Nucl Med Biol 2000; 27: 249-254.
17. Wilson AA, Houle S. J Label Compd Radiopharm 1999; 42: 1277-1288.
18. Wilson AA, Ginovart N, Schmidt M, Meyer JH, Threlkeld PG, Houle S. J Med Chem 2000; 43: 3103-3110.
19. Vercouillie J, Tarkianen J, Halldin C, Emond P, Chalon S, Sandell J, Langer O, Guilloteau D. J Label Compd Radiopharm 2001; 44: 113-120.
20. Tarkiainen J, Vercouillie J, Emond P, Sandell J, Hiltunen J, Frangin Y, Guilloteau D, Halldin C. J Label Compd Radiopharm 2001; 44: 1013-1023.
21. Emond P, Vercouillie J, Innis R, Chalon S, Mavel S, Frangin Y, Halldin C, Besnard J-C, Guilloteau D. J Med Chem 2002; 45: 1253-1258.
22. Oya S, Choi S-R, Coenen HH, Kung HF. J Med Chem 2002; 45: 4716-4723.
23. Shiue GG, Fang P, Shuie, CY. Appl Radiat Isot 2003; 58: 183-191.
24. Shiori T, Yokoyama Y, Kasai Y, Yamada S. Tetrahedron 1976; 32: 2211-2217.
25. Kung M-P, Essman WD, Frederick D, Meegalla S, Goodman M, Mu M, Lucki I, Kung HF. Synapse 1995; 20: 316-324.
26. Weingarten H. J Org Chem 1964; 29: 3624-3626.
27. Sawyer JS. Tetrahedron 2000; 56: 5045-5065.
28. Allen FL, Koch P, Suschitzky H. Tetrahedron 1959; 6: 315-318.
29. Ohata A, Iwasaki Y, Akita Y. Synthetic Comm 1982; 82: 828.
30. Aranyos A, Old DW, Kiyomori A, Wolfe JP, Sadighi JP, Buchwald SL. J Am Chem Soc 1999; 121: 4369-4378.
31. Kalinin AV, Bower JF, Riebel P, Snieckus V. J Org Chem 1999; 64: 2986-2987.
32. Gu H, Wall SC, Rudnik G. J Biol Chem 1994; 269: 7124-7130.